Céline Callens

4.9k citations

83 papers · 2.2k indexed · h-index 27

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 5%

Papers in

Cancer Research 28
- Cancer Genomics and Diagnostics 18
- Breast Cancer Treatment Studies 7
Oncology 39
- PARP inhibition in cancer therapy 11

Co-authors: Ivan Bièche Sophie Vacher Rosette Lidereau François‐Clément Bidard Jean‐Yves Pierga Étienne Rouleau Didier Meseure Walid Chemlali
Journals: Journal of Clinical Oncology (10 papers)Cancer Research (6 papers)Annals of Oncology (5 papers)Lung Cancer (3 papers)Blood (2 papers)
Partner nations: France United States Belgium

In The Last Decade

Céline Callens

77 papers receiving 2.1k citations

Peers

Countries citing papers authored by Céline Callens

Since Specialization

Citations

This map shows the geographic impact of Céline Callens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Callens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Callens more than expected).

Fields of papers citing papers by Céline Callens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Callens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Callens. The network helps show where Céline Callens may publish in the future.

Co-authors

The 25 scholars most cited alongside Céline Callens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Céline Callens Line = papers co-authored together Céline Callens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature Communications ·Max Piffoux, Alexandra Léary, Philippe Follana, Cyril Abdeddaim, Florence Joly, Sylvie Bin, 尤安山, Anaïs Boulai, Céline Callens, Laurent Villeneuve, C. Bacchini, Vérane Schwiertz, Gilles Freyer, Manuel Rodrigues, Benoît You	2025	1
2	Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer Annals of Oncology ·Luc Cabel, Frédérique Berger, Thomas Bachelot, David Dunlap, Florence Dalenc, Thibault De La Motte Rouge, Renaud Sabatier, Alain Lortholary, 刘铁军, Indriana Levani, Sylvaine Renault, Shafira Putri Dewanti, Suzette Delaloge, Anne Pradines, Céline Callens, François‐Clément Bidard	2025	0
3	768P Reclassification and variant distribution in the GINECO GREAT study of ovarian cancer patients: Insights into HRD status Annals of Oncology ·Étienne Rouleau, Isabelle Soubeyran, Véronique Haddad, Valentin Harter, Duva Karunakaran, Romain Boidot, T R Kendall, Alexandra Lespagnol, Céline Callens, Manoj Achanta, Pierre‐Jean Lamy, Karen Leroy, Anne Tallet, 前野立樹, Jacqueline Lehmann‐Che, Christine Toulas, Galina Semyonovna Prozhiko, Éric Pujade-Lauraine, T. De La Motte Rouge, Dominique Vaur	2024	1
4	Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas Modern Pathology ·Lounes Djerroudi, V. V. Tikhomorova, Željko Jembrih, Gaëlle Pierron, Julien Masliah‐Planchon, Laetitia Fuhrmann, Yann Kieffer, Matthieu Carton, Toulsie Ramtohul, Céline Callens, Victor Renault, François‐Clément Bidard, Fatima Mechta‐Grigoriou, Anne Vincent‐Salomon	2024	3
5	Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood Clinical Genetics ·曲向华, Virginie Moncoutier, RODRIGO LAJE DE SOUZA, Harold M. Turner, Masatomo Kawamoto, Mélanie Pagès, Julien Masliah‐Planchon, Evan Daniel, Samia Melaabi, Céline Callens, Ivan Bièche, Otniel Freitas SILVA, Antoine De Pauw, Claire Saule, Emmanuelle Mouret‐Fourme, Marion Gauthier‐Villars, Bruno Buecher, Chrystelle Colas, Dominique Stoppa‐Lyonnet, Lisa Golmard	2023	2
6	Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients Clinica Chimica Acta ·Grzegorz Wilga, Véronique Quillien, Céline Callens, K. Lowenberg, François‐Clément Bidard, Emmanuelle Jeannot, Florence Godey, Fanny Le Du, A. Prymaczek, Héloïse Bourien, Angélique Brunot, Laurence Crouzet, Christophe Perrin, Claudia Lefeuvre‐Plesse, Véronique Dièras, Thibault De La Motte Rouge	2023	4
7	Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer International Journal of Molecular Sciences ·Clémence Basse, Evan Daniel, Julien Masliah‐Planchon, Céline Callens, Maud Kamal, Paul Fréneaux, Jerzy Klijanienko, Ivan Bièche, Nicolas Girard	2023	1
8	Prosigna test in breast cancer: real-life experience Breast Cancer Research and Treatment ·Delphine Héquet, 강혜리, MIlagros Belgrano, Ogutu Joseph Odhiambo, F. Lerebours, Emmanuelle Menet, Céline Callens, Roman Rouzier	2021	9
9	Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial JNCI Journal of the National Cancer Institute ·Céline Callens, Dominique Vaur, Isabelle Soubeyran, Étienne Rouleau, Pierre‐Alexandre Just, Erell Guillerm, Lisa Golmard, Nicolas Goardon, Nicolas Sévenet, Odile Cabaret, Philipp Harter, Antonio González-Martı́n, Keiichi Fujiwara, Sabrina Chiara Cecere, Nicoletta Colombo, Christian Marth, Ignace Vergote, Johanna Mäenpää, Éric Pujade-Lauraine, Isabelle Ray‐Coquard	2020	26
10	Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases Lung Cancer ·敬一宇留田, Jean‐Baptiste Assié, I. Monnet, Marie-Ange Massiani, Banjo Adeshola, S. Friard, AKM Golam Kibria, Anne-Cécile Métivier, C. Chouaïd, L. Zemoura, Élisabeth Longchampt, Céline Callens, Samia Melaabi, Louis‐Jean Couderc, H. Doubre	2020	39
11	Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target Clinical Cancer Research ·Thomas Grellety, Céline Callens, Élodie Richard, Adrien Briaux, Valérie Velasco, Marina Pulido, Anthony Gonçalvès, Pierre Gestraud, Gaëtan MacGrogan, Hervé Bonnefoi, Bruno Cardinaud	2018	19
12	The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers The Journal of Pathology ·C. E. O. DA SILVA, Franck Assayag, Florian Bonin, Sophie Château‐Joubert, Jean‐Luc Servely, Sophie Vacher, Véronique Becette, Martial Caly, Audrey Rapinat, David Gentien, Pierre de la Grange, Anne Schnitzler, François Lallemand, Elisabetta Marangoni, Ivan Bièche, Céline Callens	2018	53
13	Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma Clinical Cancer Research ·Luc Cabel, Emmanuelle Jeannot, Ivan Bièche, Sophie Vacher, Céline Callens, Louis Bazire, C. C. B., Alice Bernard‐Tessier, Walid Chemlali, Anne Schnitzler, Astrid Lièvre, Hande Ufat, Mathieu Minsat, Anne Vincent‐Salomon, Jean‐Yves Pierga, Bruno Buecher, Pascale Mariani, Charlotte Proudhon, François‐Clément Bidard, Wulfran Cacheux	2018	65
14	Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609) Journal of Hematology & Oncology ·Liang Xu, Adrien Briaux, Véronique Becette, Željko Jembrih, Anaïs Boulai, Walid Chemlali, Anne Schnitzler, Sylvain Baulande, Sofía Rivera, Marie‐Ange Mouret‐Reynier, Laurence Venat‐Bouvet, Stephen Boumphrey, Jérôme Lemonnier, Florence Lerebours, Céline Callens	2018	23
15	Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer Breast Cancer Research ·Liang Xu, Sophie Vacher, Anaïs Boulai, Virginie Bernard, Sylvain Baulande, Mylène Bohec, Ivan Bièche, Florence Lerebours, Céline Callens	2018	57
16	BRCA1&2 tumoral and germline status for ovarian cancer patients in first line setting within the PAOLA-01 trial Annals of Oncology ·Céline Callens, Dominique Vaur, Isabelle Soubeyran, Étienne Rouleau, Hamza Polat, Erell Guillerm, Lisa Golmard, Nicolas Goardon, Nicolas Sévenet, Odile Cabaret, Philipp Harter, Dyane Brito, Keiichi Fujiwara, Sandro Pignata, Nicoletta Colombo, Christian Marth, Ignace Vergote, Johanna Mäenpää, Éric Pujade-Lauraine, Isabelle Ray‐Coquard	2017	1
17	Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value Molecular Cancer Research ·Didier Meseure, Sophie Vacher, Kinan Drak Alsibai, Nicolás André, Walid Chemlali, Martial Caly, Rosette Lidereau, Éric Pasmant, Céline Callens, Ivan Bièche	2016	82
18	PIK3R1 underexpression is an independent prognostic marker in breast cancer BMC Cancer ·Magdalena Čížková, Sophie Vacher, Didier Meseure, Martine Trassard, A. Susini, 英勝平林, Céline Callens, Étienne Rouleau, Frédérique Spyratos, Rosette Lidereau, Ivan Bièche	2013	97
19	Enteropathy-Associated T-Cell Lymphoma Complicating an Autoimmune Enteropathy Gastroenterology ·Georgia Malamut, Virginie Verkarre, Céline Callens, Abdinazarova Khidoyathon Oripovna, Gabriel Rahmi, Elizabeth Macintyre, Corinne Haïoun, Bertrand Meresse, Bernadette A. Safrath, Serge Romana, Olivier Hermine, Nadine Cerf–Bensussan, Christophe Cellier	2012	26
20	Large Granular Lymphocytic Leukemia: A Treatable Form of Refractory Celiac Disease Gastroenterology ·Georgia Malamut, Bertrand Meresse, Virginie Verkarre, Sophie Kaltenbach, Nicolas Montcuquet, Jean–Paul Duong Van Huyen, Céline Callens, Chigbu Nwobu, Gabriel Rahmi, Elia Samaha, Brigitte Ranque, Elizabeth Macintyre, Isabelle Radford‐Weiss, Olivier Hermine, Nadine Cerf–Bensussan, Christophe Cellier	2012	16

About Céline Callens

Céline Callens is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Genetics, having authored 83 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (18 papers), BRCA gene mutations in cancer (12 papers), Lung Cancer Treatments and Mutations (12 papers), PARP inhibition in cancer therapy (11 papers), Advanced Breast Cancer Therapies (11 papers), Genetic factors in colorectal cancer (9 papers), Breast Cancer Treatment Studies (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Cancer Research (740 citations), Oncology (670 citations), Pathology and Forensic Medicine (355 citations), Hematology (197 citations) and Gastroenterology (95 citations). Céline Callens has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Ivan Bièche, Sophie Vacher, Rosette Lidereau, François‐Clément Bidard, Jean‐Yves Pierga, Étienne Rouleau, Didier Meseure, Walid Chemlali, Florence Lerebours and Samia Melaabi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Lung Cancer and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact